The mTOR signaling pathways regulate cell growth and are involved in multiple human diseases. Here, we identify UBTOR, a previously unannotated gene as a functional player in regulating cell growth and mTOR signaling. Reduction of UBTOR function in cultured hippocampal neurons and PC12 cells promotes neurite outgrowth. UBTOR depletion activates mTOR signaling and promotes cell growth, whilst UBTOR overexpression suppresses colony formation in cancer cell lines. Studies in cultured cells and zebrafish model show that UBTOR inhibits mTOR signaling by stabilizing the mTOR complex component DEPTOR, and ubtor gene disruption result in higher mTOR activity and aggravate HRAS (G12V) induced neoplasia in the zebrafish. Lastly, UBTOR depletion promotes tumor growth and mTOR signaling in a xenograft mouse model. Together, our results demonstrate how UBTOR regulates cell growth and neoplasia via mTOR signaling.
Mechanistic target of rapamycin (mTOR) signaling is a central pathway that controls cell metabolism, growth, proliferation and survival. Clinically the mTOR pathway is implicated in human diseases including tumor formation, obesity, epilepsy, autism and neurodegeneration [1–3]. mTOR signaling activity is regulated by various factors at multiple cellular organelles [4]. The central catalytic protein mTOR forms two complexes mTORC1 and mTORC2 through interactions with a number of proteins. These mTOR interacting proteins exert important regulatory roles on mTOR activity. A protein of interest is DEPTOR, a component of both mTOR complexes and an inhibitor of mTOR signaling found only in the vertebrate species [5]. DEPTOR is phosphorylated and ubiquitylated when mTORC1 signaling pathway is activated by serum stimulation, which subsequently results in its degradation [6–8]. Here, we identify Ubtor as a functional player in regulating cell growth and mTOR signaling. Ubtor is a vertebrate-specific, previously unannotated gene except being listed as a downregulated or mutated gene in tumor tissues [9–11]. Ubtor encodes a protein without any known functional domains. We first show reductions of Ubtor expression levels in cultured hippocampal neurons and PC12 cells promote neurite outgrowth. In addition, UBTOR depletion promotes cell growth in HEK293T and U87MG cells, whilst UBTOR overexpression suppresses colony formation in HEK293T and T24 cells. We next show reduction of Ubtor promotes mTOR signaling. Mechanistic studies in cultured cells show UBTOR interacts with DEPTOR and mTOR complexes. Further studies show UBTOR stabilizes DEPTOR and regulates DEPTOR’s ubiquitination. Lastly, ubtor gene disruption in zebrafish increases mTOR activity and aggravates HRAS (G12V) induced neoplasia in the intact animals. In parallel, Ubtor depletion promotes tumor growth and mTOR signaling in xenograft-bearing mice. Together, our results demonstrate how Ubtor regulates cell growth and neoplasia via mTOR signaling.
kiaa1024/ubtor was identified in a zebrafish enhancer-trap screen aimed to isolate genes with expression in the central nervous system (see Materials and Methods). It was an unannotated gene and present in the vertebrate species only. In situ hybridization results showed ubtor was expressed in the brain and spinal cord in the zebrafish (S1 Fig). RT-PCR results showed ubtor was additionally expressed in other tissues including internal organs in the zebrafish. Based on expression data from the Allen Mouse Brain Atlas 12] and the GENSAT [13], Ubtor gene expression patterns in the nervous system appeared conserved between the zebrafish and the mouse. To investigate the function of Ubtor, we examined neurite outgrowth in rat primary hippocampal neurons (Fig 1). Fluorescence dye Cy3 labeled small interference RNA (Cy3-siRNA) was transfected into the dissociated hippocampal neurons to knock down Ubtor expression levels (Fig 1C), and the outgrowth of the neurites were revealed by acetylated tubulin stain and measured at 36 hours post in vitro culture (HIV) and 56 HIV (Fig 1A and S2A Fig). The results showed the neurite outgrowth length was almost twice long in Ubtor knock-down hippocampal neurons compared with neurons transfected with control siRNA at 36 HIV (Fig 1B). Longer neurite outgrowth length was also observed in Ubtor knock-down hippocampal neurons at 56 HIV (S2A Fig). We next examined the nerve growth factor (NGF) induced neurite outgrowth in PC12 cells [14]. We tested both PC12 cells and a PC12 subline (ld-PC12), in which the expression level of Ubtor was higher than that in the PC12 cell line (S2D Fig). Interestingly, NGF treatment increased Ubtor mRNA levels by about six-fold in the ld-PC12 cells (Fig 1F). Small interference RNA (siRNA) was transfected into the ld-PC12 cells to knock down Ubtor expression levels (Fig 1G). After the transfected cells were treated with NGF for 48 hours, the neurite outgrowth length doubled in Ubtor knock-down cells compared with cells transfected with control siRNA (Fig 1D and 1E). Enhanced neurite outgrowth was also observed when Ubtor function was inhibited in the PC12 cells (S2B Fig). UBTOR was listed as a downregulated or mutated gene in tumor tissues in previous studies [9–11]. Expression analyses in human cancer samples by the Xena Browser (http: //xena. ucsc. edu) and the FireBrowse (http: //firebrowse. org/) tools showed UBTOR was markedly downregulated in adrenocortical cancer, pheochromocytoma and paraganglioma, and glioma (S3 Fig). Thus we examined effects of UBTOR reduction in cultured human cells by lentivirus mediated shRNA knockdowns (Fig 2B). The results showed UBTOR knock-down promoted proliferation in human HEK293T cells and human glioblastoma U87MG cells (Fig 2A). In addition, UBTOR knock-down also promoted colony formation in HEK293T cells (Fig 2C). In contrast, overexpression of UBTOR decreased colony formation in both the carcinoma T24 cells and the HEK293T cells (Fig 2D). In PC12 cells, NGF mainly acts through TrkA receptor to promote neurite outgrowth. Activated TrkA receptor functions through two major downstream signaling pathways: Ras-MAPK and PI3K pathways [15–18]. We found no difference in the phosphorylation levels of ERK1/2, a crucial kinase of the Ras-MAPK signaling pathway, between the Ubtor knock-down and control PC12 cells (S4B Fig). One important downstream target of PI3K is the mTOR complex. Phosphorylation level of RPS6 (p-S6), a read-out of mTORC1 activity, was marked higher in the Ubtor knock-down ld-PC12 cells before NGF treatment (Fig 3A). One or 3 hours after NGF was added, the p-S6 levels were increased in both the Ubtor knock-down and control cells, with higher levels in the Ubtor knock-down cells. With longer NGF treatment at 6 hours and 12 hours, the p-S6 level decreased in control cells, while in Ubtor knock-down cells the high p-S6 level was maintained (Fig 3A and 3B). NGF-induced p-S6 up-regulation was abolished by co-treatment of mTORC1 specific inhibitor rapamycin (Fig 3A and 3B). Consistent with mTORC1 activation, the cell diameters of the ld-PC12 cells with reduced Ubtor expression were larger than those of the control cells (Fig 3D). In contrast to p-S6, the phosphorylation level of AKT (S473), a read-out of mTORC2 activity, was slightly higher in the Ubtor knock-down cells (Fig 3A). Similar increases of p-S6 levels were observed in the PC12 cells when Ubtor was knocked-down; and rapamycin treatment blocked S6 phosphorylation (S4A Fig). Similar to results in the PC12 cells, the phosphorylation levels of ERK1/2 were not changed in HEK293T cells with reduced UBTOR expression (S4C Fig). Phosphorylation levels of p70 S6K (p-S6K), another read-out of mTORC1 activity, were significantly higher in UBTOR knock-down cells upon serum stimulation and rapamycin treatment blocked S6K phosphorylation in both the control and the UBTOR knock-down cells (Fig 3C). HEK293T cells with reduced UBTOR expression were also larger than control cells (Fig 3D). Protein sequence analysis tools indicated UBTOR was a transmembrane protein with most amino acid residues located in the cytoplasm. Subcellular localization results confirmed UBTOR was localized to the endoplasmic reticulum and the plasma membrane, with the bulk of protein on the cytoplasm side (Fig 4A and S5 Fig). We investigated whether UBTOR interacted with the mTOR complex. We first co-transfected HeLa cells with tagged UBTOR and mTOR components and examined their subcellular co-localization. Under basal growth condition, UBTOR co-localized with exogenously expressed DEPTOR, RPTOR, and MLST8 proteins (Fig 4B). We next validated an antibody that recognized endogenous mTOR protein (S6 Fig). We found upon serum stimulation or treatment of phenylarsine oxide (PAO), a chemical activator of mTORC1 signaling pathway [19,20], co-localization between UBTOR and endogenous mTOR was observed (Fig 4C). We further examined UBTOR-mTOR complex interaction by co-immunoprecipitation. Under basal growth condition, FLAG-tagged UBTOR co-precipitated with endogenously expressed DEPTOR protein, but not other components of mTOR complex (Fig 5A). Reciprocally, exogenously-expressed DEPTOR co-immunoprecipitated with endogenously expressed UBTOR (Fig 5B). Interestingly, when PAO was added to activate mTOR signaling, UBTOR co-immunopreciptations with endogenous DEPTOR, mTOR, RPTOR and MLST8 were observed (Fig 5A). Finally, we found the N terminal region of UBTOR (UBTOR1-467) strongly immunoprecipitated with endogenous DEPTOR under basal growth condition, and PAO treatment enhanced interactions between UBTOR1-467 and components of mTOR complexes (Fig 5C). Bacteria-source purified UBTOR1-467 directly interacted with the PDZ domain of DEPTOR (Fig 5D). These results indicated that UBTOR constitutively interacted with DEPTOR, and UBTOR may form stable interaction with the mTOR complexes under serum or PAO stimulated conditions. DEPTOR is an inhibitor of mTORC1 and mTORC2 [5,21]. DEPTOR is phosphorylated and ubiquitylated when mTOR signaling pathway is activated by serum stimulation, which results in its degradation [6–8]. In the PC12 cells, the expression level of DEPTOR was reduced by 40% after 6 hours treatment of NGF (Fig 6A), consistent with degradation of DEPTOR caused by mTOR activation. Compare with the 40% reduction in the control cells, when UBTOR level was knocked down, the expression level of DEPTOR was reduced more than five-fold before and throughout the NGF treatment (Fig 6A). Thus, these marked reductions in UBTOR knockdown cells could not solely be due to mTOR signaling activation and subsequent DEPTOR degradation. Alternatively, UBTOR might stabilize DEPTOR by its direct interaction with DEPTOR. In agreement with UBTOR’s stabilization effect on DEPTOR, knockdown of UBTOR in HEK293T cells caused significant reduction of DEPTOR under basal growth condition (Fig 6B). To further examine this issue, we transiently expressed DEPTOR in HEK293T cells and found when UBTOR was co-expressed with DEPTOR, DEPTOR’s expression level was increased (Fig 6C). The transmembrane domain of UBTOR (Δ896–916) was dispensable for the stabilization effect on DEPTOR, whilst further deletion into the C terminal region of UBTOR protein (Δ852–916) abrogated this stabilization effect (Fig 6C). As expected, the UBTOR1-467 N terminal region was required for the full stabilization effects of DEPTOR (Fig 6D), because UBTOR1-467 interacted with DEPTOR (Fig 5). The middle region of UBTOR (468–773) was not required for the stabilization of DEPTOR (Fig 6E). Previous studies have shown DEPTOR was degraded through ubiquitin-proteasome pathway [6–8]. Thus, UBTOR may stabilize DEPTOR by regulating ubiquitination of DEPTOR. Indeed, UBTOR reduced the ubiquitination level of DEPTOR when they were co-expressed in HEK293T cells (Fig 6F and 6G). To investigate Ubtor’s functions in intact animals, ubtor gene was disrupted in zebrafish by TALEN and CRISPR/Cas9 mediated mutagenesis (see Materials and Methods). The targeted gene disruption resulted in frame-shift and multiple stop codons in the Ubtor coding sequence. Thus no functional Ubtor protein could be made in the homozygous mutant. The homozygous ubtor mutant had no gross developmental abnormalities. They were of similar sizes as their wild type siblings and were fertile under standard raising and maintaining conditions. Results from behavior tests showed ubtor mutant had enhanced fear-evoked freezing and compromised C-start responses (S7 Fig), suggesting ubtor mutation had subtle but significant effects on neurodevelopment and animal physiology. To determine if UBTOR’s regulation of mTOR signaling also occur in intact animals, we examined p-S6K levels in ubtor mutant and control larvae at 5 dpf, and found p-S6K was increased approximately 4-fold in the brains of ubtor mutant compared with the controls (Fig 7A). To further examine the effects of ubtor mutation on the mTOR signaling, zebrafish of 13. 5 dpf were fasted for 12 hours to down-regulate, then refed with ample food for 12 hours to activate the mTOR activities. The brain tissues of fasted and fed zebrafish were analyzed for the levels of p-S6K and p-S6. Similar to results in rodents, food-deprivation reduced the levels of p-S6K and p-S6, and feeding restored those phosphorylation levels. The ubtor mutation caused significantly higher levels of p-S6K and p-S6 in the fasted animals, and significantly higher p-S6 levels in the refed animals (Fig 7B). Thus, ubtor mutation caused significant upregulation of the mTOR signaling in the intact animals. HRAS (G12V), a dominant-active form of human oncogene HRAS, can promote tumor formation when overexpressed in zebrafish embryos [22]. Consistent with the in vitro effects of UBTOR knockdowns on cell growth and colony formation in the cultured cells, microinjection of the HRAS (G12V) construct into zebrafish ubtor mutant embryos increased neoplasia rate to over 70% compared with about 30% for the injection into the wild type controls (Fig 7C). In total, 19 out of the 59 wild type control zebrafish developed tumors, whilst 26 out of the 37 ubtor mutants had tumors (χ12 = 13. 23, P < 0. 001). To further examine effects of UBTOR depletion on tumor growth in a mammalian model, we injected nude mice with U87MG cells. UBTOR-depleted U87MG cells formed significantly larger tumors than the control cells did in the nude mice (Fig 8A and 8B). Histopathology results showed UBTOR-depleted KD tumors were composed of pleomorphic cells featuring high cell density and high nuclear-cytoplasmic ratio (Fig 8C). The Ki-67 indexes were also significantly higher in the UBTOR-depleted KD tumors (Fig 8D). These features were consistent with high malignancy. Immunoblot results showed expression levels of S6 and p-S6 were elevated 4- and 3-fold in the UBTOR-depleted tumors (Fig 8E). Thus, UBTOR depletion promoted tumor growth and mTOR signaling in the xenograft mouse model.
In this study, UBTOR depletion promotes neurite and cellular growth, whilst UBTOR overexpression suppresses colony formation in cancer cell lines. Mechanistic studies in cultured cells revealed UBTOR stabilized DEPTOR, a component of the mTOR complexes, to inhibit the mTOR signaling. Investigations in the zebrafish model further showed disruption of ubtor gene upregulated the mTOR signaling and promoted HRAS (G12V) mediated tumor formation in intact animals. Similarly, UBTOR depletion promoted tumor growth and mTOR signaling in a xenograft mouse model. These findings demonstrate how Ubtor regulates cellular growth and neoplasia via mTOR signaling. Ubtor is an unannotated gene and present in the vertebrate species only. It encodes a protein without any known functional domains despite of exhaustive sequence homology-based searches [23–25]. Ubtor protein is highly conserved in the vertebrates, with the shark protein shares 55% identities with the human protein. Searches of protein prediction servers [26–27] and protein-protein interaction databases [28] provided no clues into the function of Ubtor protein. No previous studies have indicated the function of the Ubtor gene or protein product, except that UBTOR gene was listed as one of the top down-regulated genes in adrenocortical adenoma [10], and a top-ranked mutated gene in pancreatic cancer [9,11]. Expression analyses of human tumor samples also indicated UBTOR was markedly downregulated in adrenocortical cancer, pheochromocytoma and paraganglioma, and glioma. The present study highlights Ubtor’s functions in the cellular growth and the mTOR signaling. Abnormal activation of the mTOR signaling may provide explanation why UBTOR is downregulated or mutated in tumor tissues. Consistent with this view, our results show UBTOR knock-down promote growth in HEK293T and U87MG cells, and overexpression of UBTOR reduced colony formation in both the HEK293T cells and the carcinoma T24 cells. Enhancement of HRASG12V mediated tumor formation in the homozygous ubtor zebrafish mutant and larger xenograft tumor growth of UBOTR-depleted U87MG cells in the nude mice further support involvement of Ubtor in neoplasia. Interestingly, we show that NGF treatment in PC12 cells upregulate Ubtor expression. The induction of higher Ubtor expressions levels upon mTOR signaling activation may keep the mTOR signaling activity in check. Thus, Ubtor constitutes a novel negative feedback mechanism [29–31] to control mTOR signaling. mTOR signaling activity is tightly regulated by various interacting proteins of the catalytic mTOR protein. DEPTOR is an integral component of both mTOC complexes and it functions an inhibitor of the mTOR signaling. Previous studies show that DEPTOR is ubiquitylated when mTOR signaling pathway is activated, which results in its degradation [6–8]. Our results show that UBTOR reduces ubiquitination of DEPTOR and stabilizes DEPTOR expression levels. Because the N terminal UBTOR1-467 binds to DEPTOR, a parsimonious model may indicate UBTOR is a deubiquitinating enzyme (DUB). Standard sequence-based homology searches fail to reveal an existence of DUB domain or any other functional domains in the UBTOR protein [23], neither do other specialized methods meant to detect remote homologies [24,25]. However, the primary sequences of DUB are diverse [32,33]. Future studies will be required to determine if DUBTOR harbors deubiquitinating activity, or other mechanisms such as interference with the DEPTOR E3 ligase SCF [34] or trapping of mTOR complexes on the endoplasmic reticulum are involved. In summary, our study provides insights into how Ubtor regulate cellular growth and mTOR signaling. Manipulations of Ubtor function may potentially be utilized to optimize mTOR signaling activities for treatments of cancers and other diseases.
The animal use protocols were reviewed and approved by the The Fudan University Shanghai Medical College Institutional Animal Care and Use Committee (110307–084,130227–092, and 150119–088). All animals were handled in accordance with the NRC Guide for the Care and Use of Laboratory Animals and the Fudan University Regulations on Animal Experiments. Zebrafish were maintained in a recirculating water system according to standard protocols [35]. Lines used in this study include AB, Tg (UAS: EGFP), Tg (ubtor: GAL4FF), and ubtor mutant. The wild type (wt) AB line was obtained from the University of Oregon Zebrafish Facility. The Tg (UAS: EGFP) line was a gift from K. Kawakami [36]. The Tg (ubtor: GAL4FF) line was obtained from an enhancer trap screen, and the ubtor mutant line was generated by targeted gene disruption, both using the AB line as the subject (see below). The enhancer-trap vector used in this study contains minimal transposable elements of Tol2, a super core basal promoter, and coding sequence for a modified version of Gal4 transcriptional activator [37]. A mixture of the enhancer-trap vector and Tol2 transposase mRNA was microinjected into one-cell stage embryos. Transgenic founder fish were identified and selected based on EGFP expression patterns after crossing the injected fish with a Tg (UAS: EGFP) reporter line. Transgenic founder fish were outcrossed with the AB line for three generations before high-efficiency thermal asymmetric interlaced PCR [38,39] was used to map the genomic insertion site of the enhancer trap vector. In the Tg (ubtor: GAL4FF) line, the enhancer-trap vector was mapped to the second intron of an uncharacterized gene on chromosome 7, which was subsequently named ubtor as results showed its protein product regulated protein ubiquitination and mTOR signaling. The mammalian Kiaa1024/Ubtor gene has two orthologs in the zebrafish genome. The trapped ortholog on chromosome 7 has a higher sequence identity to the mammalian sequences and was named ubtora (59% identity to the human protein sequence). The other ortholog on chromosome 18 was named ubtorb (26% identity to the human protein sequence). In situ hybridization results showed the ubtorb gene was transiently expressed in the Rohn-Beard cells between 24 and 72 hpf, and in a few cells in the trigeminal region after 72 hpf. Thus, it was unlikely to play significant roles in experiments in this study. To simplify the descriptions, the zebrafish ubtora gene was referred to as ubtor throughout this manuscript. To disrupt the ubtor gene in the zebrafish, three lesions were introduced into the zebrafish genome via the TALEN [40] and CRSPR/Cas9 mediated targeted gene modifications (see S1 Table for target site sequences and lesion information). This produced a 7-base deletion at position 22, a 10-base deletion at position 1319, and a 7-base insertion at position 1989 into the coding sequence of ubtor. These three frame-shift mutations introduced multiple stop codons to the Ubtor coding sequence. Thus, no functional protein product can be made in the homozygous mutant. This ubtor mutant line (ubtord10) was outcrossed with the AB line for 5 generations and then used in this study. The primer sequences, the target sequences and sources of siRNAs and Lentiviral shRNAs were listed in S1 Table. Plasmid constructs were generated via standard cloning methods. Construct descriptions, sources of antibodies and cell lines were listed in S2 Table. Operant conditioning was carried out using an apparatus built from a published design with modifications [41]. Briefly, four tanks of 13 cm x 5 cm x 5 cm (L x W x H) were placed on top of a LCD screen. Single zebrafish of 2 month old were placed into each tank with water 3 cm deep. During a 10 min adaptation period, a visual cue (blue checkerboard) was presented by the LCD screen on one side of each box for 10 sec and then on the other side for 10 sec. No electric shock was given during adaptation. During the conditioning period, the visual cue was presented on one side of each box. Free-moving zebrafish received a 0. 2 sec 0. 8V/cm electric shock whenever it entered the visual conditioned side of the tank and lingered for more than 0. 5 sec. A 5 sec break period was provided after each shock, and the maximal number of shocks received by a fish within one minute period was limited to 3. The conditioning period lasted for 15 min, and two conditioning session were given, with the visual cue switching to the other side in the second session. Then the visual cue was removed for 30 min. For retrieval test, the CS visual cue was presented on one side of each box for 2 min. No electric shock was given during retrieval. During the entire test, a computer running MATLAB scripts took live images from an infra-red camera at 10 frames per second, tracked the fish movements, presented the visual cues, and delivered the electric shocks. C-start response was carried out using an apparatus built from a published design with modifications [42]. Briefly, a 5 by 4 test grid was laser-cut onto a 70 mm x 50 mm x 2 mm (L x W x T) acrylic plate. A small vibrator rated at 12,000 rpm was fixed into the acrylic plate and driven by an Arduino micro-controller. The plate was placed on top of four steel balls and positioned by blocks on four corners. After each grid well was filled with single 5 dpf zebrafish, a 20–50 ms long current was sent to the vibrator to shake the plate and elicit C-starts. A high speed camera recorded the C-start response at 400–500 frames per second. Preliminary tests showed ubtor mutant fish exhibited reduced C-start after repetitive stimulations. Thus, ten repetitive stimuli were first given at 1 second intervals, then one minute later another stimulus was delivered and the C-start responses were recorded and analyzed. Primary hippocampal neurons were dissected from day 18 embryonic Sprague Dawley (SD) rats and cultured using a previously reported method [43]. Briefly, hippocampus was dissected out by fine forceps and digested in 0. 05% trypsin-EDTA solution for 15 minutes in a 37 °C incubator. Digestion was stopped by DMEM/F12 medium with 10% FBS and neurons were collected by centrifuging at 1000 rpm for 8 minutes and re-suspended in DMEM/F12 medium with 10% FBS. Then neurons were plated on coverslips coated with poly-D-lysine at a density of 4 x 104 cells/cm2. Twelve hours later, culture medium was replaced by neurobasal medium supplemented with 2% B27 (GIBCO, Life Technologies). siRNAs were transfected at the time of cell plating using Lipofectamine RNAiMAX (Thermos Scientific). Cells were lysed in 2 x SDS sample buffer (100 mM Tris-HCl pH 6. 8,4% SDS, 0. 02% bromophenol blue, 20% glycerol and 200 mM DTT) then boiled at 95°C for 10 min. Proteins in cell lysates were resolved by 6%-20% SDS-PAGE, and tank-transferred onto nitrocellulose membranes. Membranes were probed with the primary antibodies overnight and detected with HRP conjugated secondary antibodies (see S2 Table). Immuno-signals were developed by enhanced chemiluminescence, recorded by a FluorChem E system (ProteinSimple), and analyzed by ImageJ. For immunoprecipitation, cell lysates were incubated with anti-FLAG-M2 beads (Sigma-Aldrich) or anti-HA-beads (Sigma-Aldrich) at 4°C for 4 hours, and then the beads were washed with lysis buffer for 3 times. Finally, the beads were mixed with 2 x SDS sample buffer (100 mM Tris-HCl, pH 6. 8,4% SDS, 0. 02% bromophenol blue 20% glycerol and 200 mM DTT) and boiled at 95°C for 10 minutes. For pull down assays, cell lysates and GST-tagged proteins purified from bacteria were mixed with glutathione Sepharose beads (GE Life Sciences) at 4°C for 4 hours. Beads were washed 3 times with lysis buffer and boiled with 2 x SDS sample buffer at 95°C for 10 minutes. Bacteria BL21 (DE3) expressing GST-tagged or His-tagged proteins were incubated with bacterium lysis buffer (20 mM Tris-Cl, pH 8. 0,500 mM NaCl, 1 mM DTT, 5% glycerol, 1% TritonX-100, protease inhibitor cocktail, 300 ug/ml lysozyme) at 4°C for 1 hour then disrupted with sonication. The lysates were cleared by centrifugation and then incubated with glutathione Sepharose or Ni-NTA Agarose beads at 4°C for 1 hour. For GST-tagged proteins, the beads were washed three times with the lysis buffer and the GST-tagged proteins were eluted with elution buffer (50 mM Tris-Cl, pH 8,150 mM NaCl, 1 mM DTT, 5% glycerol, 1% TritonX-100) containing 10 mM glutathione. For His-tagged protein, the beads were washed three times with the lysis buffer containing 20 mM imidazole and the His-tagged proteins were eluted with elution buffer containing 500 mM imidazole. Cells were plated at 1500 cells/well in 96-well plate. The substrate WST-8 from the CCK-8 kit (Dojindo) was added from 6 hours to 4 days post plating and incubated for 4 hours, followed by absorbance measurement at 450 nm. Cells were plated at 2 x 104 (HEK293T) or 5 x 104 (T24) cells/dish in a 6 cm diameter petri-dish and then transfected with plasmid constructs as indicated. Puromycin was added to the culture medium at 1 μg/ml and then the cells were fixed and stained with 0. 01% crystal violet after two weeks. A Tol2-pCMV-GFP-HRAS (G12V) plasmid mixed with Tol2 transposase mRNA was injected to zebrafish embryos at one cell stage. Fish of one month old were examined for neoplasia by fluorescence microscopy and paraffin section of the tumors. To generate xenograft tumors, a total of 1x106 U87MG cells transfected with lentivirus negative control (NC) or UBTOR Lenti-1 shRNAs were suspended in 100 μl of MEM medium without serum and implanted subcutaneously into the flanks of 7-week-old female BALB/c nude mice. The tumor volume was measured every other days by a digital caliper. At the end point, portions of the xenograft tumors were fixed with 4% paraformaldehyde, paraffin embedded, sectioned, and subjected to hematoxylin/eosin and Ki-67 staining. The remaining tumor tissues were processed for protein extraction and subsequent immunoblot analyses. Cells were briefly washed with PBS and fixed with 4% paraformaldehyde for 10 minutes at room temperature. Fixed cells were washed with PBS and then post-fixed with methanol at -20°C for 15 minutes. After permeabilization with 0. 5% TritonX-100 in PBS for 7 min, cells were blocked with blocking solution (PBS containing 2% sheep serum, 2% goat serum 0. 2% BSA and 0. 1% Tween-20) and incubated overnight at 4°C with primary antibodies diluted in blocking solution. Cells were then washed with PBS containing 0. 1% Tween-20 and incubated with secondary antibodies (see S1 Table) for 2 hours at room temperature. Pearson’s correlation coefficients were measured using ImageJ package Fiji. Data are expressed as mean ± sem. Significance values are denoted as: *: P < 0. 05, **: P < 0. 01, ***: P < 0. 001, and ****: P < 0. 0001. Sample sizes for each figure are given in the figure legends. All quantified data are representative of at least three biological repeats. Significance of differences was assessed by two-tailed Student’s t- test, one sample t-test, or two-way ANOVA analysis when appropriate.
Cell growth is a fundamental aspect of cell behavior in all organisms. The mTOR signaling pathways are essential for cell growth and clinically mis-regulation of the mTOR pathways are implicated in human diseases including tumor formation, obesity, epilepsy, autism and neurodegeneration. Here, we identify a novel gene, Ubtor as a functional player in regulating cell growth and mTOR signaling. Inhibiting Ubtor function promotes cell growth in neurons and cancer cells. Increasing Ubtor function reduces cancer cell growth. Functional analyses in human cells and the zebrafish model indicate Ubtor inhibits mTOR signaling by stabilizing the mTOR complex component DEPTOR, and ubtor gene disruption resulted in higher mTOR activity and aggravated cancer formation in the zebrafish. UBTOR depletion promotes tumor growth and mTOR signaling in xenograft-bearing mice. Thus our study provide evidence that Ubtor constitutes a novel negative feedback mechanism to control mTOR signaling and cell growth, and manipulations of Ubtor function may potentially be utilized to optimize mTOR signaling activities for treatments of cancers and other diseases.
fish
molecular probe techniques
gene regulation
cell processes
vertebrates
neurites
animals
neuroscience
animal models
osteichthyes
research design
model organisms
experimental organism systems
cell growth
molecular biology techniques
neuronal dendrites
research and analysis methods
small interfering rnas
immunoblot analysis
animal cells
gene expression
gene disruption
molecular biology
quantitative analysis
biochemistry
rna
zebrafish
cellular neuroscience
eukaryota
cell biology
nucleic acids
neurons
genetics
biology and life sciences
cellular types
non-coding rna
organisms
UBTOR/KIAA1024 regulates neurite outgrowth and neoplasia through mTOR signaling